222 related articles for article (PubMed ID: 29968962)
21. The role of WT1 in Wilms tumorigenesis.
Coppes MJ; Campbell CE; Williams BR
FASEB J; 1993 Jul; 7(10):886-95. PubMed ID: 8393819
[TBL] [Abstract][Full Text] [Related]
22. Wilms tumour histology is determined by distinct types of precursor lesions and not epigenetic changes.
Fukuzawa R; Anaka MR; Heathcott RW; McNoe LA; Morison IM; Perlman EJ; Reeve AE
J Pathol; 2008 Aug; 215(4):377-87. PubMed ID: 18484682
[TBL] [Abstract][Full Text] [Related]
23. [Glomerulopathy in Denys-Drash syndrome. Case report of a model disease].
Stallmach T; Neuhaus TJ; Kösters R; Hailemariam S
Pathologe; 1998 May; 19(3):230-4. PubMed ID: 9648150
[TBL] [Abstract][Full Text] [Related]
24. Establishment of a Conditionally Immortalized Wilms Tumor Cell Line with a Homozygous WT1 Deletion within a Heterozygous 11p13 Deletion and UPD Limited to 11p15.
Brandt A; Löhers K; Beier M; Leube B; de Torres C; Mora J; Arora P; Jat PS; Royer-Pokora B
PLoS One; 2016; 11(5):e0155561. PubMed ID: 27213811
[TBL] [Abstract][Full Text] [Related]
25. WT1-Mutant Wilms Tumor Progression Is Associated With Diverting Clonal Mutations of CTNNB1.
Duhme C; Busch M; Heine E; de Torres C; Mora J; Royer-Pokora B
J Pediatr Hematol Oncol; 2021 Mar; 43(2):e180-e183. PubMed ID: 31876779
[TBL] [Abstract][Full Text] [Related]
26. Homozygous somatic Wt1 point mutations in sporadic unilateral Wilms tumor.
Coppes MJ; Liefers GJ; Paul P; Yeger H; Williams BR
Proc Natl Acad Sci U S A; 1993 Feb; 90(4):1416-9. PubMed ID: 8381965
[TBL] [Abstract][Full Text] [Related]
27. Loss of heterozygosity mapping in Wilms tumor indicates the involvement of three distinct regions and a limited role for nondisjunction or mitotic recombination.
Coppes MJ; Bonetta L; Huang A; Hoban P; Chilton-MacNeill S; Campbell CE; Weksberg R; Yeger H; Reeve AE; Williams BR
Genes Chromosomes Cancer; 1992 Nov; 5(4):326-34. PubMed ID: 1283321
[TBL] [Abstract][Full Text] [Related]
28. Allelotyping in Wilms tumors identifies a putative third tumor suppressor gene on chromosome 11.
Radice P; Perotti D; De Benedetti V; Mondini P; Radice MT; Pilotti S; Luksch R; Fossati Bellani F; Pierotti MA
Genomics; 1995 Jun; 27(3):497-501. PubMed ID: 7558032
[TBL] [Abstract][Full Text] [Related]
29. Wilms tumor genetics: mutations in WT1, WTX, and CTNNB1 account for only about one-third of tumors.
Ruteshouser EC; Robinson SM; Huff V
Genes Chromosomes Cancer; 2008 Jun; 47(6):461-70. PubMed ID: 18311776
[TBL] [Abstract][Full Text] [Related]
30. Inactivation of WT1 in nephrogenic rests, genetic precursors to Wilms' tumour.
Park S; Bernard A; Bove KE; Sens DA; Hazen-Martin DJ; Garvin AJ; Haber DA
Nat Genet; 1993 Dec; 5(4):363-7. PubMed ID: 8298644
[TBL] [Abstract][Full Text] [Related]
31. WT1 mutations in patients with Denys-Drash syndrome: a novel mutation in exon 8 and paternal allele origin.
Nordenskjöld A; Friedman E; Anvret M
Hum Genet; 1994 Feb; 93(2):115-20. PubMed ID: 8112732
[TBL] [Abstract][Full Text] [Related]
32. Loss of heterozygosity in Wilms' tumors, studied for six putative tumor suppressor regions, is limited to chromosome 11.
Mannens M; Devilee P; Bliek J; Mandjes I; de Kraker J; Heyting C; Slater RM; Westerveld A
Cancer Res; 1990 Jun; 50(11):3279-83. PubMed ID: 2159377
[TBL] [Abstract][Full Text] [Related]
33. Allelic loss on chromosome 11p is a less frequent event in bilateral than in unilateral Wilms' tumours.
Little MH; Clarke J; Byrne J; Dunn R; Smith PJ
Eur J Cancer; 1992; 28A(11):1876-80. PubMed ID: 1356388
[TBL] [Abstract][Full Text] [Related]
34. A developmental context for multiple genetic alterations in Wilms' tumor.
Feinberg AP
J Cell Sci Suppl; 1994; 18():7-12. PubMed ID: 7883796
[TBL] [Abstract][Full Text] [Related]
35. Genome-wide loss of heterozygosity analysis of WT1-wild-type and WT1-mutant Wilms tumors.
Ruteshouser EC; Hendrickson BW; Colella S; Krahe R; Pinto L; Huff V
Genes Chromosomes Cancer; 2005 Jun; 43(2):172-80. PubMed ID: 15761866
[TBL] [Abstract][Full Text] [Related]
36. Allelic imbalance at chromosome 1q21 in Wilms tumor.
Law MH; Algar E; Little M
Cancer Genet Cytogenet; 1997 Aug; 97(1):54-9. PubMed ID: 9242218
[TBL] [Abstract][Full Text] [Related]
37. Correlation of chromosome abnormalities with presence or absence of WT1 deletions/mutations in Wilms tumor.
Nakadate H; Tsuchiya T; Maseki N; Hatae Y; Tsunematsu Y; Horikoshi Y; Ishida Y; Kikuta A; Eguchi H; Endo M; Miyake M; Sakurai M; Kaneko Y
Genes Chromosomes Cancer; 1999 May; 25(1):26-32. PubMed ID: 10221336
[TBL] [Abstract][Full Text] [Related]
38. Identical genetic changes in different histologic components of Wilms' tumors.
Zhuang Z; Merino MJ; Vortmeyer AO; Bryant B; Lash AE; Wang C; Deavers MT; Shelton WF; Kapur S; Chandra RS
J Natl Cancer Inst; 1997 Aug; 89(15):1148-52. PubMed ID: 9262253
[TBL] [Abstract][Full Text] [Related]
39. TRIM28 haploinsufficiency predisposes to Wilms tumor.
Diets IJ; Hoyer J; Ekici AB; Popp B; Hoogerbrugge N; van Reijmersdal SV; Bhaskaran R; Hadjihannas M; Vasileiou G; Thiel CT; Seven D; Uebe S; Ilencikova D; Waanders E; Mavinkurve-Groothuis AMC; Roeleveld N; de Krijger RR; Wegert J; Graf N; Vokuhl C; Agaimy A; Gessler M; Reis A; Kuiper RP; Jongmans MCJ; Metzler M
Int J Cancer; 2019 Aug; 145(4):941-951. PubMed ID: 30694527
[TBL] [Abstract][Full Text] [Related]
40. Wilms tumor genes.
Huff V; Saunders GF
Biochim Biophys Acta; 1993 Dec; 1155(3):295-306. PubMed ID: 8268188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
